Connect with us

Health

Inhaled nebulized interferon beta-1a (SNG001) helps COVID-19 patients recovers – News-Medical.Net

Now, a team of researchers at the Synairgen Research, Southampton General Hospital, Southampton, United Kingdom, has found that inhaled nebulized interferon beta-1a…

Published

on

Amid the coronavirus disease (COVID-19) pandemic, scientists and health experts race to develop drugs and vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Many scientists resorted to repurposing approved drugs to be used on infected patients to help them recover.
Now, a team of researchers at the Synairgen Research, Southampton General Hospital, Southampton, United Kingdom, has found that inhaled nebulized interferon beta-1a (SNG001), a drug used for multiple sclerosis,…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending